WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60


Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :
Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here


Track Your Article



Ohri Richa*, Aroshikha, Tomar Deepali and Sharma Sandeep


Deplorably asthma is the most common chronic disease worldwide among children’s. Asthma is ranked 16th among the leading causes of years lived with disability and 28th among the leading cause of deaths with approximately 250,000 reported deaths annually. It affects around 23.5 million people (5-10%) including 7% of children. Montelukast is a potent antagonist of cysteinyl leukotrienes and it represents as the first category of drug which is effective in numerous biological and pathophysiological mechanisms involved in asthma. It improves theasthmatic symptoms, rescue pulmonary function and liberates medication use, and abridged the rate of exacerbation and the level of blood eosinophils, in mild-to-moderate asthmatics patients that were not treated with inhaled corticosteroids (ICS). The aim of present work is to improve the purification method of montelukast intermediate at 7th stage (MT07) of its manufacturing process. The quality improvement is achieved by using methanol in water as solvent in different ratios for purification to get better yield of more potent, stable and compatible drug in fewer expenses of time and money.

Keywords: Montelukast; Pathophysiology; Leukotrienes; Asthmatic; Potent and Compatible.

[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More